Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1093/ehjcvp/pvaa030

http://scihub22266oqcxt.onion/10.1093/ehjcvp/pvaa030
suck pdf from google scholar
32286607!7184353!32286607
unlimited free pdf from europmc32286607    free
PDF from PMC    free
html from PMC    free

suck abstract from ncbi


Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
pmid32286607      Eur+Heart+J+Cardiovasc+Pharmacother 2020 ; 6 (4): 248-251
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Might renin-angiotensin system blockers play a role in the COVID-19 pandemic? #MMPMID32286607
  • Battistoni A; Volpe M
  • Eur Heart J Cardiovasc Pharmacother 2020[Jul]; 6 (4): 248-251 PMID32286607show ga
  • Since December 2019, a new coronavirus, named SARS-CoV-2, has spread globally, affecting >200 000 people worldwide with the so-called COVID-19 disease. The scientific community is actively and constantly working to identify the mechanisms involved in the diffusion of this virus and the pathogenesis of the infection, with its most frequent and severe complication, namely interstitial pneumonia. To date, SARS-CoV-2 is known to enter the host cells via the angiotensin-converting enzyme 2 protein. For this reason, the hypothesis that drugs capable of increasing the expression of this protein may have a role in the spread of the virus and in the symptomatology of affected patients has taken hold. The purpose of this Editorial is to briefly show the evidence currently available in this regard and to provide ideas for future research.
  • |*Renin-Angiotensin System[MESH]
  • |Acute Lung Injury/etiology/*metabolism[MESH]
  • |Angiotensin II Type 1 Receptor Blockers/*therapeutic use[MESH]
  • |Angiotensin II/metabolism[MESH]
  • |Angiotensin-Converting Enzyme 2[MESH]
  • |Angiotensin-Converting Enzyme Inhibitors/*therapeutic use[MESH]
  • |Betacoronavirus/*metabolism[MESH]
  • |COVID-19[MESH]
  • |Coronavirus Infections/complications/*metabolism[MESH]
  • |Humans[MESH]
  • |Hypertension/complications/*drug therapy[MESH]
  • |Pandemics[MESH]
  • |Peptidyl-Dipeptidase A/*metabolism[MESH]
  • |Pneumonia, Viral/complications/*metabolism[MESH]
  • |Receptor, Angiotensin, Type 1/metabolism[MESH]
  • |SARS-CoV-2[MESH]
  • |Spike Glycoprotein, Coronavirus/metabolism[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box